Pancreatic Cancer Research

at Royal Liverpool University Hospital

Examples of some of the activity in Liverpool

Proteomics of pancreatic cancer and of the tumour environment looking for new targets.
Role of CapG in pancreatic cancer - new target identified from above.
Gene therapy for pancreatic cancer based on a mutated MTBP gene.
Molecular diagnosis in high risk patients.
Identifying the causative gene in Familial Pancreatic Cancer.
Phase I/II trial using a new super humanized tumour specific antibody.
Phase I/II trial of the FIRST ever proper Gene Therapy Trial for pancreatic cancer.
Phase III GemCap trial in advanced pancreatic cancer.
ESPAC-1, 2, 3 phase III trials in resected pancreatic cancer.

last updated 16th February 2004